-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OUuuN5Dab/6nZ10mFeSI9OfpaW0/y9kAbvrOGf+jVg/1uEn0K8S/lYSolnu8tNw4 4RJxDRnaoFqzm6AXjRUbQg== 0001235802-04-000110.txt : 20040512 0001235802-04-000110.hdr.sgml : 20040512 20040512155130 ACCESSION NUMBER: 0001235802-04-000110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040510 FILED AS OF DATE: 20040512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 582301143 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 BARCLAY BLVD STE 280 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 MAIL ADDRESS: STREET 1: 111 BARCLAY BLVD STE 280 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MANGANO ROSS J CENTRAL INDEX KEY: 0001013724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 04799441 BUSINESS ADDRESS: STREET 1: C/O OLIVER ESTATE INC STREET 2: 112 W JEFFERSON STREET SUITE 613 CITY: SOUTH BEND STATE: IN ZIP: 46601 BUSINESS PHONE: 2192328213 MAIL ADDRESS: STREET 1: 112 WEST FEFFERSON BOULEVARD STREET 2: SUITE 613 CITY: SOUTH BEND STATE: IN ZIP: 46634 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2004-05-10 0 0001023024 BIOSANTE PHARMACEUTICALS INC BPA 0001013724 MANGANO ROSS J P.O. BOX 1655 SOUTH BEND IN 46634 1 0 0 0 Common Stock 2004-05-10 4 A 0 152 A 29456 D Common Stock 1498349 I By JO & Co. Common Stock 33333 I By Trust Common Stock 33333 I By Trust Common Stock 33333 I By Trust Common Stock 100000 I Held as investment advisor Mr. Mangano acquired these shares as a stock award for director compensation granted under BioSante Pharmaceuticals' Amended and Restated 1998 Stock Plan. N/A Shares are held indirectly by Mr. Mangano in various trusts of which Mr. Mangano is the trustee. Shares are indirectly held by Mr. Mangano as an investment advisor on behalf of an individual. /s/ Ross Mangano, by Phillip B. Donenberg, attorney-in-fact 2004-05-11 -----END PRIVACY-ENHANCED MESSAGE-----